Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo
暂无分享,去创建一个
Sylvie Bertholet | Farhat Afrin | Carmen M. Collazo-Custodio | A. Sher | R. Goldszmid | S. Bertholet | M. Houde | M. Desjardins | A. Debrabant | A. Morrot | D. Sacks | F. Afrin | Michel Desjardins | Alan Sher | Alain Debrabant | David Sacks | Romina Goldszmid | Alexandre Morrot | Carmen Collazo-Custodio | Mathieu Houde
[1] J. Neefjes,et al. The many roads to cross-presentation , 2005, The Journal of experimental medicine.
[2] S. Grinstein,et al. Quantitative and Dynamic Assessment of the Contribution of the ER to Phagosome Formation , 2005, Cell.
[3] Y. Belkaid,et al. Antigen Requirements for Efficient Priming of CD8+ T Cells by Leishmania major-Infected Dendritic Cells , 2005, Infection and Immunity.
[4] N. Shastri,et al. Class I Major Histocompatibility Complex Presentation of Antigens That Escape from the Parasitophorous Vacuole of Toxoplasma gondii , 2005, Infection and Immunity.
[5] K. Rock,et al. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. , 2004, Immunity.
[6] D. Tscharke,et al. CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates , 2004, Science.
[7] T. Cover,et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. , 2003, Blood.
[8] R. Tampé,et al. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Davoust,et al. ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.
[10] Etienne Gagnon,et al. Phagosomes are competent organelles for antigen cross-presentation , 2003, Nature.
[11] A. G. Grandea,et al. Tapasin−/− and TAP1−/− Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH1 , 2003, The Journal of Immunology.
[12] Y. Belkaid,et al. CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major , 2002, The Journal of Immunology.
[13] F. Lechner,et al. Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.
[14] S. Beverley,et al. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. , 2001, Experimental parasitology.
[15] J. Yewdell,et al. Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo , 2001, The Journal of Immunology.
[16] J. Yewdell,et al. Cut and trim: generating MHC class I peptide ligands. , 2001, Current opinion in immunology.
[17] E. Kominami,et al. Generation of both MHC class I‐ and class II‐restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes , 2000, FEBS letters.
[18] Y. Belkaid,et al. A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.
[19] L. Kaer,et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Cresswell. Intracellular Surveillance: Controlling the Assembly of MHC Class I‐Peptide Complexes , 2000, Traffic.
[21] Sebastian Amigorena,et al. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells , 1999, Nature Cell Biology.
[22] J. Neefjes,et al. Recycling MHC class I molecules and endosomal peptide loading. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] T. Theander,et al. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. , 1999, Clinical immunology.
[24] Mattias Svensson,et al. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow‐derived dendritic cells , 1999, European journal of immunology.
[25] C. Harding,et al. Activation of Human CD8+ αβ TCR+ Cells by Mycobacterium tuberculosis Via an Alternate Class I MHC Antigen-Processing Pathway , 1999, The Journal of Immunology.
[26] D. Roos,et al. Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. , 1998, Molecular and biochemical parasitology.
[27] P. Ricciardi-Castagnoli,et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[29] A. Diehl,et al. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. , 1997, Journal of immunology.
[30] D. Mcmahon-Pratt,et al. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells. , 1997, Journal of immunology.
[31] D. Busch,et al. MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses , 1997, Immunological reviews.
[32] R. Kurlander,et al. Characterization of the murine H2–M3wt‐restricted CD8 response against a hydrophobic, protease‐resistant, phospholipid‐associated antigen from Listeria monocytogenes , 1997, Immunological reviews.
[33] J. Pfeifer,et al. Major histocompatibility complex class I presentation of ovalbumin peptide 257–264 from exogenous sources: protein context influences the degree of TAP‐independent presentation , 1996, European journal of immunology.
[34] K. Rock,et al. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Harding,et al. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. , 1996, Journal of immunology.
[36] H. Dockrell,et al. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro , 1996, Immunology.
[37] K. Heeg,et al. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. , 1995, Immunology.
[38] G. Splitter,et al. CD8+ Type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I‐ and class II‐deficient mice , 1995, European journal of immunology.
[39] J. Reimann,et al. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I‐restricted epitope presentation , 1995, European journal of immunology.
[40] M. Kovacsovics-Bankowski,et al. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.
[41] P. Romero,et al. Leishmania major infection in mice primes for specific major histocompatibility complex class I‐restricted CD8+ cytotoxic T cell responses , 1994, European journal of immunology.
[42] F. Conceição-Silva,et al. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis , 1994, Infection and immunity.
[43] J. Pfeifer,et al. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.
[44] A. Sher,et al. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. , 1993, Journal of immunology.
[45] I. Müller. Role of T cell subsets during the recall of immunologic memory to Leishmania major , 1992, European journal of immunology.
[46] G. Griffiths,et al. A T. cruzi-secreted protein immunologically related to the complement component C9: Evidence for membrane pore-forming activity at low pH , 1990, Cell.
[47] R. Mshana,et al. In Situ Characterization of the Cutaneous Immune Response in Ethiopian Cutaneous Leishmaniasis , 1987, Scandinavian journal of immunology.
[48] K. Chang,et al. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. , 1976, Science.
[49] M. Bevan. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.
[50] L. Kaer,et al. Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH , 2003 .
[51] R. Andino,et al. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen , 1999, Nature.
[52] C. Harding,et al. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. , 1999, Journal of immunology.
[53] E. Jaffee,et al. Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses. , 1994, Ciba Foundation symposium.
[54] A. Sher,et al. CD8+ T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. , 1993, Research in immunology.
[55] P. Vassalli,et al. Involvement of specific Lyt‐2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis , 1987, European journal of immunology.